PL348107A1 - Therapy for improving cognition - Google Patents

Therapy for improving cognition

Info

Publication number: PL348107A1
Authority: PL; Poland
Prior art keywords: therapy; improving cognition; cognition; improving
Prior art date: 1998-10-16

Application number

PL99348107A

Inventor

Nijs Paul Leonce Irma De

Wim Louis Julien Parys

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-16

Filing date

1999-10-12

Publication date

2002-05-06

1999-10-12 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2002-05-06 Publication of PL348107A1 publication Critical patent/PL348107A1/en

Links

230000019771 cognition Effects 0.000 title 1
238000002560 therapeutic procedure Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)

PL99348107A 1998-10-16 1999-10-12 Therapy for improving cognition PL348107A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98203454		1998-10-16
PCT/EP1999/007804 WO2000023057A2 (en)	1998-10-16	1999-10-12	Atypical antiphsychotic in combination with acetylcholinesterase inhibitor for improving cognition

Publications (1)

Publication Number	Publication Date
PL348107A1 true PL348107A1 (en)	2002-05-06

Family

ID=8234219

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL99348107A PL348107A1 (en)	1998-10-16	1999-10-12	Therapy for improving cognition

Country Status (20)

Country	Link
EP (1)	EP1121131A2 (en)
JP (1)	JP2002527469A (en)
KR (1)	KR20010072878A (en)
CN (1)	CN1367697A (en)
AU (1)	AU6472799A (en)
BG (1)	BG105302A (en)
BR (1)	BR9914419A (en)
CA (1)	CA2345767A1 (en)
EE (1)	EE200100136A (en)
HK (1)	HK1039745A1 (en)
HR (1)	HRP20010262A2 (en)
HU (1)	HUP0103781A3 (en)
ID (1)	ID28441A (en)
IL (1)	IL142588A0 (en)
NO (1)	NO20011403L (en)
PL (1)	PL348107A1 (en)
SK (1)	SK4592001A3 (en)
TR (1)	TR200101082T2 (en)
WO (1)	WO2000023057A2 (en)
ZA (1)	ZA200103081B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0102841D0 (en) *	2001-02-05	2001-03-21	Novartis Ag	Organic compounds
AU2006201188B2 (en) *	2001-02-05	2007-11-15	Novartis Ag	New use of iloperidone
ES2358416T3 (en)	2001-10-30	2011-05-10	Novartis Ag	PROLONGED RELEASE FORMATIONS OF ILOPERIDONE AND POLYMER IN THE FORM OF A STAR.
GB0216416D0 (en)	2002-07-15	2002-08-21	Novartis Ag	Organic compounds
US20040192754A1 (en) *	2003-03-24	2004-09-30	Shapira Nathan Andrew	Methods for treating idiopathic hyperhidrosis and associated conditions
TW200501962A (en) *	2003-04-01	2005-01-16	Novartis Ag	Use of carbamazepine derivatives for the treatment of agitation in dementia patients
CA2552221A1 (en) *	2003-12-31	2005-07-21	Actavis Group Hf	Donepezil formulations
AU2004325725A1 (en) *	2004-12-10	2006-06-22	Abbott Laboratories	Fused bicycloheterocycle substituted quinuclidine derivatives
US8278345B2 (en)	2006-11-09	2012-10-02	Probiodrug Ag	Inhibitors of glutaminyl cyclase
JP5523107B2 (en)	2006-11-30	2014-06-18	プロビオドルグエージー	Novel inhibitors of glutaminyl cyclase
EP2481408A3 (en)	2007-03-01	2013-01-09	Probiodrug AG	New use of glutaminyl cyclase inhibitors
WO2008128985A1 (en)	2007-04-18	2008-10-30	Probiodrug Ag	Thiourea derivatives as glutaminyl cyclase inhibitors
MX2007008642A (en) *	2007-07-16	2009-02-25	World Trade Imp Export Wtie Ag	Pharmaceutical composition comprising the combination of a benzisoxazolic derived agent and a reversible inhibiting agent of the cholinesterase enzyme prescribed for the control and treatment of psychotic disorders and dementias.
US20110212928A1 (en)	2010-02-09	2011-09-01	The Johns Hopkins University	Methods and compositions for improving cognitive function
JP6026284B2 (en)	2010-03-03	2016-11-16	プロビオドルグエージー	Inhibitors of glutaminyl cyclase
US8269019B2 (en)	2010-03-10	2012-09-18	Probiodrug Ag	Inhibitors
WO2011131748A2 (en)	2010-04-21	2011-10-27	Probiodrug Ag	Novel inhibitors
ES2570167T3 (en)	2011-03-16	2016-05-17	Probiodrug Ag	Benzimidazole derivatives as glutaminyl cyclase inhibitors
WO2014078568A1 (en)	2012-11-14	2014-05-22	The Johns Hopkins University	Methods and compositions for treating schizophrenia
EP2968220B1 (en)	2013-03-15	2021-05-05	Agenebio, Inc.	Methods and compositions for improving cognitive function
WO2014144663A1 (en)	2013-03-15	2014-09-18	The Johns Hopkins University	Methods and compositions for improving cognitive function
NZ738682A (en)	2015-05-22	2022-01-28	Agenebio Inc	Extended release pharmaceutical compositions of levetiracetam
PL3461819T3 (en)	2017-09-29	2020-11-30	Probiodrug Ag	Inhibitors of glutaminyl cyclase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0584185B1 (en) *	1991-05-14	1999-08-11	Ernir Snorrason	Treatment of fatigue syndrome with cholinesterase inhibitors
US5336675A (en) *	1991-05-14	1994-08-09	Ernir Snorrason	Method of treating mania in humans
DK1011678T3 (en) *	1997-08-11	2008-05-05	Univ South Florida	Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders
US6228875B1 (en) *	1998-04-14	2001-05-08	The General Hospital Corporation	Methods for treating neuropsychiatric disorders

1999
- 1999-10-12 IL IL14258899A patent/IL142588A0/en unknown
- 1999-10-12 TR TR2001/01082T patent/TR200101082T2/en unknown
- 1999-10-12 EE EEP200100136A patent/EE200100136A/en unknown
- 1999-10-12 CN CN99812184A patent/CN1367697A/en active Pending
- 1999-10-12 HU HU0103781A patent/HUP0103781A3/en unknown
- 1999-10-12 CA CA002345767A patent/CA2345767A1/en not_active Abandoned
- 1999-10-12 ID IDW20010828A patent/ID28441A/en unknown
- 1999-10-12 PL PL99348107A patent/PL348107A1/en unknown
- 1999-10-12 KR KR1020017002286A patent/KR20010072878A/en not_active Withdrawn
- 1999-10-12 SK SK459-2001A patent/SK4592001A3/en unknown
- 1999-10-12 BR BR9914419-0A patent/BR9914419A/en not_active IP Right Cessation
- 1999-10-12 HK HK02100158.6A patent/HK1039745A1/en unknown
- 1999-10-12 HR HR20010262A patent/HRP20010262A2/en not_active Application Discontinuation
- 1999-10-12 JP JP2000576832A patent/JP2002527469A/en not_active Withdrawn
- 1999-10-12 AU AU64727/99A patent/AU6472799A/en not_active Abandoned
- 1999-10-12 EP EP99952580A patent/EP1121131A2/en not_active Withdrawn
- 1999-10-12 WO PCT/EP1999/007804 patent/WO2000023057A2/en not_active Ceased
2001
- 2001-03-01 BG BG105302A patent/BG105302A/en unknown
- 2001-03-20 NO NO20011403A patent/NO20011403L/en not_active Application Discontinuation
- 2001-04-12 ZA ZA200103081A patent/ZA200103081B/en unknown

Also Published As

Publication number	Publication date
ZA200103081B (en)	2002-07-12
AU6472799A (en)	2000-05-08
ID28441A (en)	2001-05-24
HUP0103781A3 (en)	2003-09-29
WO2000023057A2 (en)	2000-04-27
HUP0103781A2 (en)	2002-03-28
CN1367697A (en)	2002-09-04
IL142588A0 (en)	2002-03-10
BG105302A (en)	2001-11-30
WO2000023057A3 (en)	2000-07-27
SK4592001A3 (en)	2001-12-03
CA2345767A1 (en)	2000-04-27
NO20011403D0 (en)	2001-03-20
JP2002527469A (en)	2002-08-27
KR20010072878A (en)	2001-07-31
NO20011403L (en)	2001-03-20
HK1039745A1 (en)	2002-05-10
EE200100136A (en)	2002-06-17
BR9914419A (en)	2001-06-26
HRP20010262A2 (en)	2002-06-30
EP1121131A2 (en)	2001-08-08
TR200101082T2 (en)	2001-09-21

Publication	Publication Date	Title
IL142588A0 (en)	2002-03-10	Therapy for improving cognition
AP2002002661A0 (en)	2002-12-31	Combination therapy for oesteoporosis
GB9820113D0 (en)	1998-11-11	Therapeutic agents
GB9816263D0 (en)	1998-09-23	Therapeutic agents
GB9806102D0 (en)	1998-05-20	Therapeutic agents
EP1077704A4 (en)	2002-01-30	Combination therapy for treatment of depression
GB9804885D0 (en)	1998-04-29	Therapeutic combination
GB9808663D0 (en)	1998-06-24	Therapeutic agents
GB9813576D0 (en)	1998-08-19	Therapeutic agents
GB9801234D0 (en)	1998-03-18	Therapeutic agents
GB9813006D0 (en)	1998-08-12	Therapeutic agents
GB9801210D0 (en)	1998-03-18	Therapeutic agents
AP9901436A0 (en)	1999-03-31	Therapeutic agents
GB9816556D0 (en)	1998-09-30	Therapy
HUP0101947A3 (en)	2001-12-28	Combination for the treatment of tumors
GB9801397D0 (en)	1998-03-18	Therapeutic agents
GB9801202D0 (en)	1998-03-18	Therapeutic agents
GB9808665D0 (en)	1998-06-24	Therapeutic compounds
GB9810092D0 (en)	1998-07-08	Therapeutic agents
GB9824897D0 (en)	1999-01-06	Therapeutic compounds
GB9811879D0 (en)	1998-07-29	Therapeutic agents
GB9805716D0 (en)	1998-05-13	Therapeutic agents
GB9816723D0 (en)	1998-09-30	Therapeutic agents
GB9815317D0 (en)	1998-09-16	Therapeutic agents
GB0020261D0 (en)	2000-10-04	Therapeutic treatment